Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapansutrile in early Parkinson's disease
NCT07157735Phase 2Recruiting
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapansutrile in Parkinson's disease (PD), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Feb 2026; status: recruiting.
02
Drugs
dapansutrile
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07157735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07157735.